Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ETHY-001 in healthy volunteers and Thyroid Eye Disease
NCT07885605Phase 1Recruiting
- Start
- Jul 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in thyroid eye disease (TED) comparing ETHY-001 with Placebo (2 arms). Primary endpoint: Overall safety profile. Started Jul 2026; status: recruiting.
02
Drugs
ETHY-001
03
Conditions
thyroid eye disease (TED)
Beyond the preview
Go deeper on NCT07885605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07885605.